The Effect of Counseling and Treatment Reminder Tool to Adherence with Drug and Outcome Clinic Patients with Diabetes Mellitus and Hypertension

Authors

  • Much Ilham Novalisa Aji Wibowo Fakultas Farmasi, Universitas Muhammadiyah Purwokerto ,
  • Didik Setiawan Fakultas Farmasi, Universitas Muhammadiyah Purwokerto ,
  • Nindya Dwi Ikhwaniati Fakultas Farmasi, Universitas Muhammadiyah Purwokerto ,
  • Fitria Amalia Sukma Fakultas Farmasi, Universitas Muhammadiyah Purwokerto ,

DOI:

https://doi.org/10.35814/jifi.v18i2.761

Keywords:

Counseling, adherence, diabetes mellitus, hypertension, MARS

Abstract

The World Health Organization declares Diabetes Mellitus and Hypertension as one of the health

emergencies. Adherence to medication is an important factor in controlling this disease. Research is needed to find out the combination of counseling and treatment reminder aids will aff ect adherence and clinical outcomes. Pretest-posttest design was conducted in February 2019 - May 2019. Sample population was Prolanis patients at Puskesmas Kembaran I, Purwokerto Timur II and Sumbang I. The inclusion criteria were 66 patients with type 2 diabetes and 72 patients with hypertension. The determination of the pretest-posttest group was by simple random sampling. The adherence instrument used MARS, counseling and medication reminder tools according to pharmaceutical counseling guidelines. The respondents were women, low education, normal BMI, didn’t work, combination of Diabetes medication and single medication for Hypertension. The pretest group was categorized as non-adherent, but experienced an increase after the intervention. The interventions given also had an eff ect on improving medication adherence and controlling the clinical outcome of type 2 DM patients and hypertensive patients at the Puskesmas (p-value 0,000 <0.05). The combination of pharmacist counseling interventions with medication reminders is more eff ective in increasing medication adherence in patients with type 2 Diabetes mellitus and Hypertension.

References

Downloads

Published

2020-10-28

Issue

Vol. 18 No. 2 (2020): JIFI

Section

Articles

License

Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.

This licence applies to Author(s) and Public Reader means that the users mays :

  • SHARE:
    copy and redistribute the article in any medium or format
  • ADAPT:
    remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication)
  • ALIKE:
    If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original.
  • NO ADDITIONAL RESTRICTIONS:
    You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

It does however mean that when you use it you must:

  • ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

You may not:

  • NONCOMMERCIAL: You may not use the article for commercial purposes.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.